Tata India Pharma & Healthcare Fund Regular Growth

Tata India Pharma & Healthcare Fund Regular Growth: NAV ₹33.62, 3Y return 16.66%, 5Y 14.11%, AUM ₹1,229 Cr, expense ratio 2.40%, iNVESTT rating 4/5. Returns vs index, rolling returns, holdings, Direct vs Regular and peers, by a SEBI Registered Research Analyst.

Key facts

NAV
₹33.6163 (19 Nov 2026)
1-year return
9.17%
3-year return (CAGR)
16.66%
5-year return (CAGR)
14.11%
Fund size (AUM)
₹1,229 Cr
Expense ratio
2.40%
Exit load
0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.
Minimum investment
Rs.5000 & in multiples of Re.1/- thereafter.
Category
Sectoral Fund
Benchmark
BSE Healthcare TRI
Riskometer
Very High Risk
Fund manager
Rajat Srivastava
Launch date
4 Dec 2015
iNVESTT rating
4 out of 5

Frequently asked questions

What is the NAV of Tata India Pharma & Healthcare Fund Regular Growth today?

The NAV of Tata India Pharma & Healthcare Fund Regular Growth is ₹33.6163 as of 19 Nov 2026.

What are the returns of Tata India Pharma & Healthcare Fund Regular Growth?

9.17% over 1 year, 16.66% a year over 3 years, 14.11% a year over 5 years. Past returns do not guarantee future returns; compare them with the benchmark and rolling returns on this page.

What is the expense ratio of Tata India Pharma & Healthcare Fund Regular Growth?

The expense ratio (TER) is 2.40% a year. This Regular plan includes a distributor commission; the Direct plan of the same fund costs less.

What is the AUM (fund size) of Tata India Pharma & Healthcare Fund Regular Growth?

Tata India Pharma & Healthcare Fund Regular Growth manages ₹1,229 Cr.

Is there an exit load on Tata India Pharma & Healthcare Fund Regular Growth?

Exit load: 0.25% of NAV if redeemed /switched out before 30 days from the date of allotment..

How risky is Tata India Pharma & Healthcare Fund Regular Growth?

Its SEBI riskometer is "Very High Risk" and it is in the Sectoral Fund category.

What is the benchmark of Tata India Pharma & Healthcare Fund Regular Growth?

The benchmark is BSE Healthcare TRI. This page compares the fund with its benchmark's total-return index (TRI).

What is the iNVESTT rating of Tata India Pharma & Healthcare Fund Regular Growth?

4 out of 5. iNVESTT rating: where the fund ranks in its category over 1, 3 and 5 years (3 and 5 years count most). Top fifth = 5 stars. A past-performance measure, not a recommendation.

Research by iNVESTT, a SEBI Registered Research Analyst (INH000010858). Data from AMFI. Mutual fund investments are subject to market risks; past performance does not guarantee future returns.

Mutual fund research · Fund screener · Compare this fund · SIP calculator · Personal advisory